NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin 300134, China.
Department of Obster & Gynecol, Shengli Oilfield Center Hospital, Dongying, Shandong 257000, China.
Biomed Pharmacother. 2023 Aug;164:114897. doi: 10.1016/j.biopha.2023.114897. Epub 2023 May 22.
Diabetic nephropathy (DN) is characterized by tubulointerstitial fibrosis caused by epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells. Although ferroptosis promotes DN development, the specific pathological process that is affected by ferroptosis in DN remains unclear. Herein, EMT-related changes, including increased α-smooth muscle actin (α-SMA) and Vimentin expression and decreased E-cadherin expression, were observed in the renal tissues of streptozotocin-induced DN mice and high glucose-cultured human renal proximal tubular (HK-2) cells. Treatment with ferrostatin-1 (Fer-1) ameliorated these changes and rescued renal pathological injury in diabetic mice. Interestingly, endoplasmic reticulum stress (ERS) was activated during EMT progression in DN. Inhibiting ERS improved the expression of EMT-associated indicators and further rescued the characteristic changes in ferroptosis caused by high glucose, including reactive oxygen species (ROS) accumulation, iron overload, increased lipid peroxidation product generation, and reduced mitochondrial cristae. Moreover, overexpression of XBP1 increased Hrd1 expression and inhibited NFE2-related factor 2 (Nrf2) expression, which could enhance cell susceptibility to ferroptosis. Co-immunoprecipitation (Co-IP) and ubiquitylation assays indicated that Hrd1 interacted with and ubiquitinated Nrf2 under high-glucose conditions. Collectively, our results demonstrated that ERS triggers ferroptosis-related EMT progression through the XBP1-Hrd1-Nrf2 pathway, which provides new insights into potential mechanisms for delaying EMT progression in DN.
糖尿病肾病(DN)的特征是肾小管上皮细胞发生上皮-间充质转化(EMT),导致小管间质纤维化。尽管铁死亡促进了 DN 的发展,但铁死亡在 DN 中影响的具体病理过程尚不清楚。在此,我们观察到链脲佐菌素诱导的 DN 小鼠的肾脏组织和高糖培养的人近端肾小管(HK-2)细胞中发生 EMT 相关变化,包括α-平滑肌肌动蛋白(α-SMA)和波形蛋白表达增加以及 E-钙黏蛋白表达减少。用 Ferrostatine-1(Fer-1)治疗可改善这些变化并挽救糖尿病小鼠的肾脏病理损伤。有趣的是,在 DN 中 EMT 进展过程中会激活内质网应激(ERS)。抑制 ERS 可改善 EMT 相关指标的表达,并进一步挽救高糖引起的铁死亡的特征变化,包括活性氧(ROS)积累、铁过载、脂质过氧化产物生成增加和线粒体嵴减少。此外,XBP1 的过表达增加了 Hrd1 的表达并抑制了 NFE2 相关因子 2(Nrf2)的表达,这可以增强细胞对铁死亡的敏感性。免疫共沉淀(Co-IP)和泛素化实验表明,在高葡萄糖条件下,Hrd1 与 Nrf2 相互作用并使其泛素化。综上所述,我们的结果表明,ERS 通过 XBP1-Hrd1-Nrf2 途径触发与铁死亡相关的 EMT 进展,这为延缓 DN 中 EMT 进展的潜在机制提供了新的见解。